1. Home
  2. TWO vs CDNA Comparison

TWO vs CDNA Comparison

Compare TWO & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Two Harbors Investment Corp

TWO

Two Harbors Investment Corp

HOLD

Current Price

$12.62

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.95

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWO
CDNA
Founded
2009
1998
Country
United States
United States
Employees
486
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
TWO
CDNA
Price
$12.62
$19.95
Analyst Decision
Hold
Buy
Analyst Count
7
6
Target Price
$12.56
$28.00
AVG Volume (30 Days)
2.3M
733.8K
Earning Date
04-28-2026
04-28-2026
Dividend Yield
11.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$48,324,000.00
Revenue This Year
N/A
$16.01
Revenue Next Year
N/A
$11.31
P/E Ratio
N/A
$409.60
Revenue Growth
N/A
18.93
52 Week Low
$8.84
$10.96
52 Week High
$14.17
$23.24

Technical Indicators

Market Signals
Indicator
TWO
CDNA
Relative Strength Index (RSI) 72.21 47.72
Support Level $9.55 $16.63
Resistance Level $12.67 $21.20
Average True Range (ATR) 0.16 1.33
MACD 0.05 -0.22
Stochastic Oscillator 93.60 38.34

Price Performance

Historical Comparison
TWO
CDNA

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, residential mortgage loans, mortgage servicing rights, and commercial real estate. The majority of its investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. The company derives revenues mainly from its MSR and Agency RMBS portfolio, including servicing fee income, float income, and interest income, as well as mortgage loan origination activities established to support the MSR portfolio. Its investment portfolio is subject to market risks, mainly interest rate, basis, and prepayment risk. The majority of income is generated by available-for-sale securities.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: